Cargando…
Current and future immunotherapy approaches in ovarian cancer
Ovarian cancer (OC) is the major cause of gynecologic cancer deaths and relapse is common despite advances in surgery and systemic chemotherapy. Therefore, novel treatments are required to improve long-term outcomes of the disease. Efficacy of immunotherapy was demonstrated in many tumors and it has...
Autores principales: | Demircan, Nazım Can, Boussios, Stergios, Tasci, Tolga, Öztürk, Mehmet Akif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812210/ https://www.ncbi.nlm.nih.gov/pubmed/33490226 http://dx.doi.org/10.21037/atm-20-4499 |
Ejemplares similares
-
Ovarian cancer: state of the art and perspectives of clinical research
por: Boussios, Stergios, et al.
Publicado: (2020) -
Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
por: Uccello, Mario, et al.
Publicado: (2020) -
Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
por: Boussios, Stergios, et al.
Publicado: (2020) -
Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020) -
Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)